July 21, 2022
The University of Cincinnati is poised to welcome its largest class ever this fall, for which UC President Neville G. Pinto credits the entire university community.
September 15, 2022
HealthDay highlighted recent University of Cincinnati research that found administering immunotherapy drug pembrolizumab before surgery for oral cavity cancer did not increase rates of complication during and after surgery.
September 16, 2022
WLWT and Yahoo News highlighted work being done by University of Cincinnati Cancer Center researchers to advance cancer care through new immunotherapy and cellular therapy treatments.
August 18, 2022
Design World featured the University of Cincinnati's Frank Rybicki in an article about different ways CAD and 3-D printing have helped advance medical care.
August 17, 2022
The University of Cincinnati's Michael Hegener, PharmD, was a panelist on WVXU's Cincinnati Edition discussing the under-regulated dietary supplements industry.
August 15, 2022
The University of Cincinnati's Elizabeth Shaughnessy, MD, PhD, joined 55KRC's Simply Medicine program to discuss breast cancer survivorship and screening in light of the recent death of actress and singer Olivia Newton-John.
August 10, 2022
Medium featured the research of the University of Cincinnati's Jiajie Diao, PhD, who recently published a paper showing early results that light-activated proteins can help normalize dysfunction within cells.
August 10, 2022
The Cincinnati Enquirer highlights research by UC associate professor Steven Ellis and his students who are discovering new insights about ancient civilizations in Italy.
August 11, 2022
The University of Cincinnati's Joseph Broderick, MD, provided comments in a TCTMD article reviewing the results of a recent study that found administering the drug tirofiban before endovascular thrombectomy does not improve functional outcomes in patients.
August 5, 2022
The University of Cincinnati's John Byrd, MD, was featured in a Cure article on the FDA's approval of the tablet form of the drug Calquence to treat multiple blood cancers.